Practice Areas

Testosterone Therapy

Testosterone Therapy Linked with Increase of Heart Attacks, Strokes, and Blood Clots

Testosterone products, which are prescribed to treat low testosterone (“Low T”) in men have become increasingly popular among older adults and young men seeking physical enhancement and to counter effects associated with the natural aging process. Although testosterone products were represented to be safe and effective for the treatment of low testosterone, the drugs have been associated with an increased risk of serious medical problems and death, including heart attacks, strokes, deep vein thrombosis (DVT), and pulmonary embolisms (PE) (blood clots). Several scientific studies have found that testosterone products significantly increase the risk of suffering from a heart attack and stroke. If you or a loved one has taken testosterone products and have suffered from a heart attack, stroke, blood clots, or any other health problem, contact the Testosterone Therapy attorneys in our Pennsylvania, New Jersey and New York offices.

About Testosterone Therapy Drugs

Testosterone products are dangerous pharmaceuticals intended to treat hypogonadism or “low testosterone.” There are many Testosterone Therapy drugs on the market that are the subject of ongoing or potential lawsuits, including:

  • AndroGelⓇ

  • AndrodermⓇ

  • AxironⓇ

  • Bio-T-GelⓇ

  • DelatestrylⓇ

  • Depo-TestosteroneⓇ

  • ForestaⓇ

  • StriantⓇ

  • TestimⓇ

  • TestopelⓇ

Testosterone Therapy Lawsuits

There are currently more than 280 cases related to testosterone therapy ingestion pending across the country. Many of these cases relate to heart attacks, strokes, and blood clots, but the medications’ side effects are not limited to the development of these conditions.

In November of 2013, a JAMA study was released entitled “Association of Testosterone Therapy with Mortality, Myocardial Infarction, and Stroke in Men with Low Testosterone Levels” which indicated that testosterone drugs raised the risk of death, heart attack and stroke by about 30%. On January 29, 2014, a study was released in PLUS ONE entitled “Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men” which indicated that testosterone use doubled the risk of heart attacks in men over sixty-five years old and men younger than sixty-five with a previous diagnosis of heart disease. On June 19, 2014, the FDA began requiring the manufacturers of testosterone drugs to include a general warning on all approved testosterone products concerning the risks of blood clots in veins, including DVT, PE, and venous thromboembolism (VTE). This requirement supplemented the FDA’s ongoing evaluation of the risks of stroke, heart attack, and death in patients taking testosterone products.

Testosterone Therapy defendants are accused of defectively designing and manufacturing testosterone drugs, failing to warn of the serious risks of the drugs, and negligently designing, manufacturing, labeling, and promoting the products. The complaints also alleged that the defendants breached warranties to consumers concerning the safety of the medications and engaged in fraud to the general public and medical community regarding the risks of the drugs. Many plaintiffs are seeking punitive damages due to the conduct of the defendants and the serious nature of the injuries sustained by the consumers of testosterone medications.

Contact a Locks Law Firm Testosterone Therapy Lawyer

If you or a loved one has taken any Testosterone Therapy products and experienced any of the side effects described above, or other health conditions, contact the Locks Law Firm today. We urge you to contact us immediately as all claims are subject to strict requirements on when a case must be filed by. Our Pennsylvania, New Jersey and New York attorneys can provide information about filing a Testosterone Therapy lawsuit during a free, confidential consultation and case evaluation.

Do I have a case? Free Case Evaluation